Histology
Non-Small Cell Carcinoma
CI-CAN-00001292Explore in graph →
1,752 active trials47 approved drugs589 evidence items
- NCIt
- C65151
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00001292Explore in graph →
Clinical trials
6,757 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,046)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00721981 | An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy | terminated | — | 120 | AstraZenecaINDUSTRY | 1 | Dec 10, 2010 | clinicaltrials |
| NCT01258127 | Pemetrexed/Carboplatin vs Vinorelbine/Carboplatin in Patients With Completely Resected Non-small Cell Lung Cancer (NSCLC) | unknown | — | 134 | Shanghai Nancy Medical Sci-Tech Co. LtdINDUSTRY | 1 |
| Dec 10, 2010 |
| clinicaltrials |
| NCT00192036 | Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer | completed | Phase 2 | 49 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 9, 2010 | clinicaltrials |
| NCT00434668 | Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer(TOLEDO) | completed | Phase 2 | 99 | University Hospital, AntwerpOTHER | 1 | Nov 30, 2010 | clinicaltrials |
| NCT01249053 | Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma | unknown | — | 100 | China Medical University HospitalOTHER | 1 | Nov 29, 2010 | clinicaltrials |
| NCT01249066 | Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma | unknown | — | 100 | China Medical University HospitalOTHER | 1 | Nov 29, 2010 | clinicaltrials |
| NCT00380718 | Chemotherapy for Patients With Non-Small Cell Lung Cancer | completed | Phase 4 | 33 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 16, 2010 | clinicaltrials |
| NCT00222404 | Pharmacogenomic Study Realized on "Non-small Cell Lung Carcinoma"(Pharmacogenos) | completed | — | 556 | University Hospital, GrenobleOTHER | 1 | Nov 5, 2010 | clinicaltrials |
| NCT00874328 | A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) | unknown | Phase 1 / Phase 2 | 74 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 25, 2010 | clinicaltrials |
| NCT00101920 | ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) | completed | Phase 2 | 50 | AmgenINDUSTRY | 0 | Oct 15, 2010 | clinicaltrials |
| NCT00350792 | Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients | completed | Phase 2 | 62 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 13, 2010 | clinicaltrials |
| NCT00085813 | Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 70 | GlaxoSmithKlineINDUSTRY | 3 | Oct 4, 2010 | clinicaltrials |
| NCT01211002 | Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC) | unknown | Phase 4 | 170 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Sep 29, 2010 | clinicaltrials |
| NCT01210053 | Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | 30 | Third Military Medical UniversityOTHER | 1 | Sep 28, 2010 | clinicaltrials |
| NCT00315185 | Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer | completed | Phase 2 | 53 | Fox Chase Cancer CenterOTHER | 1 | Sep 23, 2010 | clinicaltrials |
| NCT01192230 | Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients | unknown | Phase 2 | 30 | Fudan UniversityOTHER | 1 | Sep 16, 2010 | clinicaltrials |
| NCT01201044 | Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC)(DO201001) | unknown | N/A | 80 | Third Military Medical UniversityOTHER | 1 | Sep 14, 2010 | clinicaltrials |
| NCT00409006 | Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 3 | Sep 9, 2010 | clinicaltrials |
| NCT01192243 | Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients | unknown | Phase 2 | 68 | Fudan UniversityOTHER | 1 | Sep 3, 2010 | clinicaltrials |
| NCT00312819 | Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer | completed | Phase 2 / Phase 3 | 60 | Hadassah Medical OrganizationOTHER | 1 | Aug 31, 2010 | clinicaltrials |
| NCT00329472 | Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer | withdrawn | Phase 3 | 0 | Samsung Medical CenterOTHER | 0 | Aug 27, 2010 | clinicaltrials |
| NCT00544960 | A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer | completed | Phase 2 | 106 | Ascenta TherapeuticsINDUSTRY | 3 | Aug 27, 2010 | clinicaltrials |
| NCT01187290 | Preoperative Chemoradiotherapy Versus Chemotherapy Alone in Nonsmall Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases | unknown | Phase 2 | 80 | Shanghai Jiao Tong University School of MedicineOTHER | 0 | Aug 24, 2010 | clinicaltrials |
| NCT00440414 | Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 320 | Hellenic Oncology Research GroupOTHER | 1 | Aug 19, 2010 | clinicaltrials |
| NCT00831909 | Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN(EPICLIN) | completed | — | 3,513 | AstraZenecaINDUSTRY | 8 | Aug 10, 2010 | clinicaltrials |
| NCT01163058 | Tyrosine Kinase Inhibitors In Metastatic Non Small Cell Lung Cancer | unknown | — | 300 | Istituto Clinico HumanitasOTHER | 1 | Jul 29, 2010 | clinicaltrials |
| NCT01170923 | FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 100 | Asan Medical CenterOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT00572325 | Concurrent Chemo-radiation Form NSCLC to a Individualized MLD(BRONC CONC MLD) | completed | — | 180 | Maastricht Radiation OncologyOTHER | 1 | Jul 21, 2010 | clinicaltrials |
| NCT00573040 | Radiotherapy for NSCLC to a Individualized MLD(BRONC MLD) | completed | — | 180 | Maastricht Radiation OncologyOTHER | 1 | Jul 21, 2010 | clinicaltrials |
| NCT00797238 | DNA Repair Genes and Outcomes in Patients With Stage III NSCLC | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Jul 15, 2010 | clinicaltrials |
| NCT00316225 | Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen | completed | Phase 2 | 31 | Eli Lilly and CompanyINDUSTRY | 3 | Jul 9, 2010 | clinicaltrials |
| NCT01158144 | Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902) | unknown | Phase 2 | 134 | Zhejiang Cancer HospitalOTHER | 1 | Jul 8, 2010 | clinicaltrials |
| NCT01158170 | Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001) | unknown | Phase 3 | 200 | Zhejiang Cancer HospitalOTHER | 1 | Jul 8, 2010 | clinicaltrials |
| NCT00783471 | Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)(DOPERLO) | terminated | Phase 2 | 51 | Hellenic Cooperative Oncology GroupOTHER | 1 | Jun 16, 2010 | clinicaltrials |
| NCT01131429 | A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations | unknown | Phase 2 | 60 | Chinese PLA General HospitalOTHER | 1 | May 27, 2010 | clinicaltrials |
| NCT01130766 | Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC) | unknown | Phase 3 | 176 | Samsung Medical CenterOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT01130779 | The Continuation of Erlotinib | unknown | Phase 2 | 23 | Samsung Medical CenterOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT01000740 | A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa | completed | Phase 4 | 59 | AstraZenecaINDUSTRY | 1 | May 21, 2010 | clinicaltrials |
| NCT00113516 | A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 84 | PfizerINDUSTRY | 3 | May 18, 2010 | clinicaltrials |
| NCT01091376 | Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)(RT0901) | unknown | Phase 2 | 75 | Zhejiang Cancer HospitalOTHER | 1 | May 17, 2010 | clinicaltrials |
| NCT01124253 | Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC)(Dengshan) | completed | Phase 3 | 250 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | May 17, 2010 | clinicaltrials |
| NCT00956280 | Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer | completed | — | 100 | AstraZenecaINDUSTRY | 1 | May 13, 2010 | clinicaltrials |
| NCT00318136 | A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE) | completed | Phase 2 | 47 | Genentech, Inc.INDUSTRY | 0 | May 11, 2010 | clinicaltrials |
| NCT00198393 | Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV | completed | Phase 2 | 126 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Apr 30, 2010 | clinicaltrials |
| NCT01105182 | Radiofrequency Ablation Combined With Chemotherapy for Pulmonary Tumors(FACPT) | unknown | — | 48 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Apr 16, 2010 | clinicaltrials |
| NCT00063388 | Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer | completed | Phase 2 | 66 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 12, 2010 | clinicaltrials |
| NCT00034541 | Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 32 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00097214 | Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 57 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00097227 | Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 165 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00054899 | An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer | completed | Phase 1 | 18 | EpimmuneINDUSTRY | 1 | Mar 24, 2010 | clinicaltrials |
Data updated 24 days agoSource updated Dec 10, 2010source: clinicaltrials